(Q45273801)

11 December 2017

title

Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells (English)

1 reference

11 December 2017

0 references

metastatic breast cancer

1 reference

Taryn L Green

1

1 reference

11 December 2017

Mark F Santos

2

1 reference

11 December 2017

Ahmed A Ejaeidi

3

1 reference

11 December 2017

Barbara S Craft

4

1 reference

11 December 2017

Robert E Lewis

5

1 reference

11 December 2017

Julius M Cruse

6

1 reference

11 December 2017

publication date

14 May 2014

1 reference

Experimental and Molecular Pathology

11 December 2017

published in

1 reference

11 December 2017

volume

97

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

44-48

1 reference

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Progress in using circulating tumor cell information to improve metastatic breast cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen-induced T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Dendritic cells and cytokines in immune rejection of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Pattern recognition receptors: doubling up for the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

HER2-positive circulating tumor cells in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

NF-kappaB activation in development and progression of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor control of the adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

mRNA is an endogenous ligand for Toll-like receptor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptors, wound healing, and carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor signaling in cell proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Biomarkers characterization of circulating tumour cells in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

DAMPening inflammation by modulating TLR signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

TLR3 can directly trigger apoptosis in human cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Circulating tumor cells in breast cancer: a tool whose time has come of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Statistical considerations for enumeration of circulating tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Tumour escape from immune surveillance through dendritic cell inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.05.003

10.1016/J.YEXMP.2014.05.003

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference